Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery

• প্রধান লেখক: Theodora Katopodi (লেখক), Savvas Petanidis (লেখক), Doxakis Anestakis (লেখক), Charalampos Charalampidis (লেখক), Ioanna Chatziprodromidou (লেখক), George Floros (লেখক), Panagiotis Eskitzis (লেখক), Paul Zarogoulidis (লেখক), Charilaos Koulouris (লেখক), Christina Sevva (লেখক), Konstantinos Papadopoulos (লেখক), Marios Dagher (লেখক), Nikolaos Varsamis (লেখক), Vasiliki Theodorou (লেখক), Chrysi Maria Mystakidou (লেখক), Nikolaos Iason Katsios (লেখক), Konstantinos Farmakis (লেখক), Christoforos Kosmidis (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2023-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR) T cell therapy has gained a great deal of attention during the last years. However, the effectiveness of this treatment has been hampered by a number of challenges, including significant toxicities, difficu...